Insights into the role of NRF2 in cancer provided by cancer genomics

Leinonen, 2014, Role of the keap1-nrf2 pathway in cancer, Adv Cancer Res, 122, 281, 10.1016/B978-0-12-420117-0.00008-6 Garraway, 2013, Lessons from the cancer genome, Cell, 153, 17, 10.1016/j.cell.2013.03.002 Gao, 2013, Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal, Sci Signal, 6, l1, 10.1126/scisignal.2004088 Cerami, 2012, The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data, Cancer Discov, 2, 401, 10.1158/2159-8290.CD-12-0095 Kensler, 2010, Nrf2: friend or foe for chemoprevention?, Carcinogenesis, 31, 90, 10.1093/carcin/bgp231 Padmanabhan, 2006, Structural basis for defects of Keap1 activity provoked by its point mutations in lung cancer, Mol Cell, 21, 689, 10.1016/j.molcel.2006.01.013 Singh, 2006, Dysfunctional KEAP1-NRF2 interaction in non-small-cell lung cancer, PLoS Med, 3, e420, 10.1371/journal.pmed.0030420 Shibata, 2008, Cancer related mutations in NRF2 impair its recognition by Keap1-Cul3 E3 ligase and promote malignancy, Proc Natl Acad Sci USA, 105, 13568, 10.1073/pnas.0806268105 Lawrence, 2013, Mutational heterogeneity in cancer and the search for new cancer-associated genes, Nature, 499, 214, 10.1038/nature12213 Cancer Genome Atlas Research Network, 2012, Comprehensive genomic characterization of squamous cell lung cancers, Nature, 489, 519, 10.1038/nature11404 Genschik, 2013, The emerging family of CULLIN3-RING ubiquitin ligases (CRL3s): cellular functions and disease implications, EMBO J, 32, 2307, 10.1038/emboj.2013.173 Cancer Genome Atlas Research Network, 2014, Comprehensive molecular profiling of lung adenocarcinoma, Nature, 511, 543, 10.1038/nature13385 Govindan, 2012, Genomic landscape of non-small cell lung cancer in smokers and never-smokers, Cell, 150, 1121, 10.1016/j.cell.2012.08.024 Hoadley, 2014, Multiplatform analysis of 12 cancer types reveals molecular classification within and across tissues of origin, Cell, 158, 929, 10.1016/j.cell.2014.06.049 Campbell, 2016, Distinct patterns of somatic genome alterations in lung adenocarcinomas and squamous cell carcinomas, Nat Genet, 48, 607, 10.1038/ng.3564 Morris, 2016, The molecular landscape of recurrent and metastatic head and neck cancers: insights from a precision oncology sequencing platform, JAMA Oncol Cancer Genome Atlas Network, 2015, Comprehensive genomic characterization of head and neck squamous cell carcinomas, Nature, 517, 576, 10.1038/nature14129 Chung, 2004, Molecular classification of head and neck squamous cell carcinomas using patterns of gene expression, Cancer Cell, 5, 489, 10.1016/S1535-6108(04)00112-6 Forner, 2012, Hepatocellular carcinoma, Lancet, 379, 1245, 10.1016/S0140-6736(11)61347-0 Totoki, 2014, Trans-ancestry mutational landscape of hepatocellular carcinoma genomes, Nat Genet, 46, 1267, 10.1038/ng.3126 Schulze, 2015, Exome sequencing of hepatocellular carcinomas identifies new mutational signatures and potential therapeutic targets, Nat Genet, 47, 505, 10.1038/ng.3252 Komatsu, 2010, The selective autophagy substrate p62 activates the stress responsive transcription factor Nrf2 through inactivation of Keap1, Nat Cell Biol, 12, 213, 10.1038/ncb2021 Denk, 2006, Are the Mallory bodies and intracellular hyaline bodies in neoplastic and non-neoplastic hepatocytes related?, J Pathol, 208, 653, 10.1002/path.1946 Ichimura, 2013, Phosphorylation of p62 activates the Keap1-Nrf2 pathway during selective autophagy, Mol Cell, 51, 618, 10.1016/j.molcel.2013.08.003 Umemura, 2016, p62, Upregulated during preneoplasia, induces hepatocellular carcinogenesis by maintaining survival of stressed HCC-initiating cells, Cancer Cell, 29, 935, 10.1016/j.ccell.2016.04.006 Saito, 2016, p62/Sqstm1 promotes malignancy of HCV-positive hepatocellular carcinoma through Nrf2-dependent metabolic reprogramming, Nat Commun, 7, 12030, 10.1038/ncomms12030 Cancer Genome Atlas Research Network, 2014, Comprehensive molecular characterization of urothelial bladder carcinoma, Nature, 507, 315, 10.1038/nature12965 Shen, 2013, The VHL/HIF axis in clear cell renal carcinoma, Semin Cancer Biol, 23, 18, 10.1016/j.semcancer.2012.06.001 Cancer Genome Atlas Research Network, 2013, Comprehensive molecular characterization of clear cell renal cell carcinoma, Nature, 499, 43, 10.1038/nature12222 Sato, 2013, Integrated molecular analysis of clear-cell renal cell carcinoma, Nat Genet, 45, 860, 10.1038/ng.2699 Li, 2013, SQSTM1 is a pathogenic target of 5q copy number gains in kidney cancer, Cancer Cell, 24, 738, 10.1016/j.ccr.2013.10.025 Launonen, 2001, Inherited susceptibility to uterine leiomyomas and renal cell cancer, Proc Natl Acad Sci USA, 98, 3387, 10.1073/pnas.051633798 Tomlinson, 2002, Germline mutations in FH predispose to dominantly inherited uterine fibroids, skin leiomyomata and papillary renal cell cancer, Nat Genet, 30, 406, 10.1038/ng849 Cancer Genome Atlas Research Network, 2016, Comprehensive molecular characterization of papillary renal-cell carcinoma, N Engl J Med, 374, 135, 10.1056/NEJMoa1505917 Kovac, 2015, Recurrent chromosomal gains and heterogeneous driver mutations characterise papillary renal cancer evolution, Nat Commun, 6, 6336, 10.1038/ncomms7336 Ooi, 2011, An antioxidant response phenotype shared between hereditary and sporadic type 2 papillary renal cell carcinoma, Cancer Cell, 20, 511, 10.1016/j.ccr.2011.08.024 Adam, 2011, Renal cyst formation in Fh1-deficient mice is independent of the Hif/Phd pathway: roles for fumarate in KEAP1 succination and Nrf2 signaling, Cancer Cell, 20, 524, 10.1016/j.ccr.2011.09.006 Kim, 2016, Characterizing genomic alterations in cancer by complementary functional associations, Nat Biotechnol, 34, 539, 10.1038/nbt.3527 Diederichs, 2016, The dark matter of the cancer genome: aberrations in regulatory elements, untranslated regions, splice sites, non-coding RNA and synonymous mutations, EMBO Mol Med, 8, 442, 10.15252/emmm.201506055 Ren, 2011, Brusatol enhances the efficacy of chemotherapy by inhibiting the Nrf2-mediated defense mechanism, Proc Natl Acad Sci USA, 108, 1433, 10.1073/pnas.1014275108 Tao, 2014, Oncogenic KRAS confers chemoresistance by upregulating NRF2, Cancer Res, 74, 7430, 10.1158/0008-5472.CAN-14-1439 Fukumoto, 2005, Overexpression of the aldo-keto reductase family protein AKR1B10 is highly correlated with smokers’ non-small cell lung carcinomas, Clin Cancer Res, 11, 1776, 10.1158/1078-0432.CCR-04-1238 Crowley, 2013, Liquid biopsy: monitoring cancer-genetics in the blood, Nat Rev Clin Oncol, 10, 472, 10.1038/nrclinonc.2013.110